Monoclonal Antibody Therapy

WHAT IS BAM TREATMENT?

With monoclonal antibody therapy, physicians now have a way to help prevent severe symptoms from developing in patients who are at a high risk.

Monoclonal antibodies are laboratory made proteins that mimic the immune system’s ability to fight off harmful pathogens.
Monoclonal antibody-based therapies have the greatest likelihood of having an impact in the earliest stages of infection before an effective immune response has been triggered.
The therapy is a one time dose of IV medication that should be administered as soon as possible after a confirmed diagnosis of COVID-19 and within 10 days of the first onset of symptoms.

Patients with mild to moderate COVID-19 who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Patient must not currently be hospitalized.
Patient must not currently require increased oxygen due to COVID infection.
Patient must be at high risk for progressing to severe COVID-19 and/or hospitalization which is defined as age >/=65 yrs and those </+ 55 years with underlying illnesses.

The elderly and/or individuals with co-morbidities may be more impacted by Covid-19. Often their weakened conditions are unmanageable in their home environment due to existing or lacking social support.
Recovery in a skilled nursing environment allows the individual to receive treatment and regain strength with the support of a licensed team of nurses and therapists.
Inpatient medical oversight by primary and specialty physicians provides valuable medical support an individual may not receive in their home setting.

For expedited patient qualification and admission arrangements, contact Stacey Downs 732.962.0041; Joanne Snyder 732.237.4873; or Jessica Saracen 609.694.1743
Same Day Admissions can occur with qualified patient cases.